🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this phase 2 study is to assess the feasibility and efficacy...
Status
Terminated
Location
Duke University Medical Center
Start Date
2020-11-04
Trial ID
NCT04434560
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
DONIMI is a phase 1b trial testing the combination of domatinostat + nivolu...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2020-01-07
Trial ID
NCT04133948
Treatments Being Tested
Rationale: The randomized trial NADINA has demonstrated that neoadjuvant tr...
Status
Recruiting
Location
Erasmus MC
Start Date
2025-04-23
Trial ID
NCT06754904
Treatments Being Tested
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma...
Status
Completed
Location
James P. Wilmot Cancer Center at University of Rochester Medical Center
Start Date
2018-07-17
Trial ID
NCT03463408
Treatments Being Tested
To determine the histopathological response rate to neo-adjuvant nivolumab ...
Status
Completed
Location
NKI-AVL
Start Date
2020-08-11
Trial ID
NCT04620200
Treatments Being Tested
The goal of this clinical trial is to investigate the safety and feasibilit...
Status
Recruiting
Location
National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital
Start Date
2026-06-29
Trial ID
NCT07501117
Treatments Being Tested
Rationale: The combination of ipilimumab and nivolumab induces relatively ...
Status
Unknown
Location
The Netherlands Cancer Institute
Start Date
2017-01-27
Trial ID
NCT02968303
Treatments Being Tested
The goal of this clinical trial is to study the impact of Neoadjuvant ipili...
Status
Recruiting
Location
Huntsman Cancer Institute
Start Date
2026-07
Trial ID
NCT06365619
Treatments Being Tested